The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

General Notices

• Revised NIAID Policy Defining the Institutes Use of the Mentored Research Scientist Career Development (K01) Award
  National Institute of Allergy and Infectious Diseases

• Pre-Application Webinar for RFA-CA-19-055 "Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trials Not Allowed)"
  National Cancer Institute

• Request for Information (RFI): National Institute of Dental and Craniofacial Research (NIDCR) Strategic Plan Fiscal Years 2020-2025
  National Institute of Dental and Craniofacial Research

Notice of Changes to Funding Opportunities

• Correction to RFA-CA-19-034 "Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities".
  National Cancer Institute

• Notice of Change to the Award Budget for PAR-18-303 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed).
  National Cancer Institute

• Notice of NIDA Participation in PAR-18-901, "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
  National Institute on Drug Abuse

• Notice of Change to Application Due Date and to the Multi-Component Application Instructions for RFA-DK-19-003, "Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)"
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice to Extend Application Deadline ,Change of Funds Available and Award Budget for RFA-FD-19-029 "Rare Disease Clinical Outcome Assessment Consortium (U01 Clinical Trial Not Allowed)."
  Food and Drug Administration

• Notice of Change to Award Project Period in PAR-19-253 Focused Technology Research and Development (R01 - Clinical Trial Not Allowed)
  National Institute of General Medical Sciences

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
  National Institute on Drug Abuse

• Notice of Intent to Publish a Funding Opportunity Announcement for the Reissue NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
  National Institute on Drug Abuse

Requests for Proposal

• Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
• Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
• Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
• Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
• Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
  National Institutes of Health

Notices of Special Interest

• Notice of Special Interest (NOSI): Accelerate Dissemination of Emerging Glycoscience Tools through Collaborations Between Developers and Early Adopters
  Office of Strategic Coordination (Common Fund)

Funding Opportunities

• Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
• Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
  National Institute on Aging
  
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu